FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2039698972> ?p ?o ?g. }

• W2039698972 endingPage "2688" @default.
• W2039698972 startingPage "2681" @default.
• W2039698972 abstract "Repeated injections of iodine-125 (125I)-labeled tumor targeting anticytokeratin monoclonal antibody (TS1) and a nonlabeled antiidiotypic monoclonal antibody against TS1 (alphaTS1) were compared with a single injection of the radiolabeled TS1 in experimental radioimmunotargeting. Anti-TS1 was used to remove nontargeting TS1.Nude mice were inoculated with HeLa Hep2 cells. The animals in Group A received a single injection of 13 MBq 125I-labeled TS1. The animals in Group B received four injections of 125I-labeled TS1 (8-13 MBq) followed by alphaTS1 24 hours later, at 2-week intervals. The mean absorbed doses were calculated according to the Medical Internal Radiation Dose Committee criteria based on repetitive radioimmunoscintigraphies during an observation period of 59 days.A 11 gray (Gy) mean dose to the tumor and 2 Gy to the whole body was achieved in Group A. Mean peak tumor uptake of 5% of the injected dose (ID), corresponding to 14% ID/g, was observed on Day 17 after a single injection of the labeled monoclonal antibody. A mean peak tumor uptake of the same order of magnitude was seen in Group B. An absolute increase in the tumor uptake was observed in Group B during the entire observation period. The mean absorbed dose to the tumors was 11 Gy at the end of the observation period, whereas the whole body dose was only 2.5 Gy in Group B. Autoradiography of the tumors at the end of the observation period confirmed an intensive heterogeneous accumulation of activity in the entire tumor.The fractionated strategy can contribute to a significant accumulation of radiolabeled TS1 in the tumors. Furthermore, the use of alphaTS1 makes it possible to increase the tumor-to-nontumor dose ratio and maintain a prolonged high activity accumulation in the tumor." @default.
• W2039698972 created "2016-06-24" @default.
• W2039698972 creator A5004144764 @default.
• W2039698972 creator A5023058487 @default.
• W2039698972 creator A5039496543 @default.
• W2039698972 creator A5043059264 @default.
• W2039698972 creator A5065820517 @default.
• W2039698972 creator A5074816302 @default.
• W2039698972 creator A5076310194 @default.
• W2039698972 creator A5088582666 @default.
• W2039698972 date "1997-12-15" @default.
• W2039698972 modified "2023-10-17" @default.
• W2039698972 title "Dosimetry of fractionated experimental radioimmunotargeting with idiotypic and anti-idiotypic anticytokeratin antibodies" @default.
• W2039698972 cites W124763997 @default.
• W2039698972 cites W1893651774 @default.
• W2039698972 cites W1978475328 @default.
• W2039698972 cites W1988323037 @default.
• W2039698972 cites W1998798256 @default.
• W2039698972 cites W2005835292 @default.
• W2039698972 cites W2016693266 @default.
• W2039698972 cites W2045083440 @default.
• W2039698972 cites W2046679177 @default.
• W2039698972 cites W2056526459 @default.
• W2039698972 cites W2062781010 @default.
• W2039698972 cites W2067403798 @default.
• W2039698972 cites W2078562507 @default.
• W2039698972 cites W2078966922 @default.
• W2039698972 cites W2081743971 @default.
• W2039698972 cites W2084377890 @default.
• W2039698972 cites W2171870822 @default.
• W2039698972 cites W2241539696 @default.
• W2039698972 cites W2318431083 @default.
• W2039698972 doi "https://doi.org/10.1002/(sici)1097-0142(19971215)80:12+<2681::aid-cncr46>3.0.co;2-5" @default.
• W2039698972 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9406725" @default.
• W2039698972 hasPublicationYear "1997" @default.
• W2039698972 type Work @default.
• W2039698972 sameAs 2039698972 @default.
• W2039698972 citedByCount "9" @default.
• W2039698972 crossrefType "journal-article" @default.
• W2039698972 hasAuthorship W2039698972A5004144764 @default.
• W2039698972 hasAuthorship W2039698972A5023058487 @default.
• W2039698972 hasAuthorship W2039698972A5039496543 @default.
• W2039698972 hasAuthorship W2039698972A5043059264 @default.
• W2039698972 hasAuthorship W2039698972A5065820517 @default.
• W2039698972 hasAuthorship W2039698972A5074816302 @default.
• W2039698972 hasAuthorship W2039698972A5076310194 @default.
• W2039698972 hasAuthorship W2039698972A5088582666 @default.
• W2039698972 hasBestOaLocation W20396989721 @default.
• W2039698972 hasConcept C142724271 @default.
• W2039698972 hasConcept C159654299 @default.
• W2039698972 hasConcept C203014093 @default.
• W2039698972 hasConcept C2776146153 @default.
• W2039698972 hasConcept C2989005 @default.
• W2039698972 hasConcept C542903549 @default.
• W2039698972 hasConcept C71924100 @default.
• W2039698972 hasConceptScore W2039698972C142724271 @default.
• W2039698972 hasConceptScore W2039698972C159654299 @default.
• W2039698972 hasConceptScore W2039698972C203014093 @default.
• W2039698972 hasConceptScore W2039698972C2776146153 @default.
• W2039698972 hasConceptScore W2039698972C2989005 @default.
• W2039698972 hasConceptScore W2039698972C542903549 @default.
• W2039698972 hasConceptScore W2039698972C71924100 @default.
• W2039698972 hasIssue "S12" @default.
• W2039698972 hasLocation W20396989721 @default.
• W2039698972 hasLocation W20396989722 @default.
• W2039698972 hasOpenAccess W2039698972 @default.
• W2039698972 hasPrimaryLocation W20396989721 @default.
• W2039698972 hasRelatedWork W1970641137 @default.
• W2039698972 hasRelatedWork W1971189917 @default.
• W2039698972 hasRelatedWork W2072105586 @default.
• W2039698972 hasRelatedWork W2087631306 @default.
• W2039698972 hasRelatedWork W2091011349 @default.
• W2039698972 hasRelatedWork W2100027804 @default.
• W2039698972 hasRelatedWork W2158284291 @default.
• W2039698972 hasRelatedWork W2280977080 @default.
• W2039698972 hasRelatedWork W2402960538 @default.
• W2039698972 hasRelatedWork W2411771071 @default.
• W2039698972 hasVolume "80" @default.
• W2039698972 isParatext "false" @default.
• W2039698972 isRetracted "false" @default.
• W2039698972 magId "2039698972" @default.
• W2039698972 workType "article" @default.